AU2004316339A1 - Opioid delivery system - Google Patents

Opioid delivery system Download PDF

Info

Publication number
AU2004316339A1
AU2004316339A1 AU2004316339A AU2004316339A AU2004316339A1 AU 2004316339 A1 AU2004316339 A1 AU 2004316339A1 AU 2004316339 A AU2004316339 A AU 2004316339A AU 2004316339 A AU2004316339 A AU 2004316339A AU 2004316339 A1 AU2004316339 A1 AU 2004316339A1
Authority
AU
Australia
Prior art keywords
opioid
formulation
mcg
fentanyl
concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2004316339A
Other languages
English (en)
Inventor
Orlando Ricardo Hung
Diana Helen Pliura
Steven Louis Shafer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gilead YM ULC
Original Assignee
YM Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/788,466 external-priority patent/US7648981B2/en
Priority claimed from PCT/CA2004/000303 external-priority patent/WO2004075879A1/en
Application filed by YM Biosciences Inc filed Critical YM Biosciences Inc
Publication of AU2004316339A1 publication Critical patent/AU2004316339A1/en
Assigned to YM BIOSCIENCES INC. reassignment YM BIOSCIENCES INC. Request for Assignment Assignors: DELEX THERAPEUTICS INC.
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU2004316339A 2003-02-28 2004-08-27 Opioid delivery system Abandoned AU2004316339A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US45033303P 2003-02-28 2003-02-28
US10/788,466 US7648981B2 (en) 2003-02-28 2004-03-01 Opioid delivery system
AUPCT/CA2004/000303 2004-03-01
PCT/CA2004/000303 WO2004075879A1 (en) 2003-02-28 2004-03-01 Opioid delivery system
PCT/CA2004/001578 WO2005082369A1 (en) 2003-02-28 2004-08-27 Opioid delivery system

Publications (1)

Publication Number Publication Date
AU2004316339A1 true AU2004316339A1 (en) 2005-09-09

Family

ID=42354335

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2004316339A Abandoned AU2004316339A1 (en) 2003-02-28 2004-08-27 Opioid delivery system

Country Status (6)

Country Link
EP (1) EP1732555A4 (de)
KR (1) KR20070011344A (de)
CN (1) CN1938027A (de)
AU (1) AU2004316339A1 (de)
NO (1) NO20064463L (de)
WO (1) WO2005082369A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2029197A2 (de) * 2006-06-21 2009-03-04 Universität Bern System zur kontrolle der verabreichung von anästhesie
KR20220126409A (ko) 2021-03-09 2022-09-16 주식회사 퍼넥티브 비대면 영어 교육 플랫폼 및 외국어 학습방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8900267D0 (en) * 1989-01-06 1989-03-08 Riker Laboratories Inc Narcotic analgesic formulations and apparatus containing same
US5451408A (en) * 1994-03-23 1995-09-19 Liposome Pain Management, Ltd. Pain management with liposome-encapsulated analgesic drugs
JP3911290B2 (ja) * 1994-05-13 2007-05-09 アラダイム コーポレーション エアゾールを含む麻酔用処方
GB9606188D0 (en) * 1996-03-23 1996-05-29 Danbiosyst Uk Pollysaccharide microspheres for the pulmonary delivery of drugs
EP1392262A1 (de) * 2001-05-24 2004-03-03 Alexza Molecular Delivery Corporation Verabreichung von arzneimittel-estern durch inhalation
US20030051728A1 (en) * 2001-06-05 2003-03-20 Lloyd Peter M. Method and device for delivering a physiologically active compound

Also Published As

Publication number Publication date
EP1732555A4 (de) 2008-07-16
WO2005082369A1 (en) 2005-09-09
NO20064463L (no) 2006-11-30
CN1938027A (zh) 2007-03-28
KR20070011344A (ko) 2007-01-24
EP1732555A1 (de) 2006-12-20

Similar Documents

Publication Publication Date Title
US20100189778A1 (en) Opioid delivery system
Henningfield et al. Nicotine delivery kinetics and abuse liability.
EP2637662B1 (de) Dosierungsschema zur sedierung mit cns7056 (remimazolam)
CA2417727C (en) Fentanyl composition for nasal administration
JPH10503753A (ja) エアゾールを含む麻酔用処方
Wagen et al. Benefits and risks of pharmacological smoking cessation therapies in chronic obstructive pulmonary disease
AU2013231976A1 (en) Methods of administering high concentrations of nitric oxide
JP2020200345A (ja) 除痛および麻酔の提供のためのジヒドロエトルフィン
Tarradell et al. Respiratory and analgesic effects of meperidine and tramadol in patients undergoing orthopedic surgery
ZA200607418B (en) Opioid delivery system
de Wit et al. Abuse potential of nicotine replacement therapies
CA2599022A1 (en) Opioid delivery system
AU2004316339A1 (en) Opioid delivery system
US7648981B2 (en) Opioid delivery system
MXPA06010062A (es) Sistema para suministrar opioides.
US11529311B2 (en) Method of using nebulized alcohol for analgesia
Weber et al. Sedation for dermatologic surgery
Gardenhire Drugs affecting the central nervous system
Kim et al. Oxycodone versus Fentanyl for Intravenous Patient-Controlled Analgesia after Laparoscopic Gynecologic Surgery
Francisco Control of breathing: how to better understand the respiratory effects of opioids
WOLLSCHLAEGER Opioid Overdose Education, Prevention, and Management
Higgins Clinical and theoretical studies with the opioid analgesic fentanyl
Shiffman et al. Nicotine Delivery Systems

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: YM BIOSCIENCES INC.

Free format text: FORMER APPLICANT(S): DELEX THERAPEUTICS INC.

MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application